Patents by Inventor James Lorens

James Lorens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030017601
    Abstract: The invention provides shuttle vectors, and methods of using shuttle vectors, capable of expression in, at least, a mammalian cell. Furthermore, the shuttle vectors are capable of replication in at least yeast, and optionally, bacterial cells. Also provided is a method wherein yeast are transformed with a shuttle vector as provided herein. Heterologous nucleic acids flanked by 5′ and 3′ ends identical to a homologous recombination site within the shuttle vector are introduced to the transformed yeast and allowed to homologously recombine with the shuttle vector such that they are inserted into the vector by the yeast organism. The shuttle vector is then recovered and transferred to a mammalian cell for expression.
    Type: Application
    Filed: January 7, 2002
    Publication date: January 23, 2003
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Ying Luo, Pei Wen Yu, James Lorens
  • Patent number: 6461813
    Abstract: The invention related to novel methods of detecting alterations in cell cycle regulation in a cell or a cell population and screening for agents capable of modulating cell cycle regulation through the use of multiparameter assays and a fluorescence-activated cell sorter (FACS) machine.
    Type: Grant
    Filed: September 21, 1998
    Date of Patent: October 8, 2002
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventor: James Lorens
  • Patent number: 6391582
    Abstract: The invention provides shuttle vectors, and methods of using shuttle vectors, capable of expression in, at least, a mammalian cell. Furthermore, the shuttle vectors are capable of replication in at least yeast, and optionally, bacterial cells. Also provided is a method wherein yeast are transformed with a shuttle vector as provided herein. Heterologous nucleic acids flanked by 5′ and 3′ ends identical to a homologous recombination site within the shuttle vector are introduced to the transformed yeast and allowed to homologously recombine with the shuttle vector such that they are inserted into the vector by the yeast organism. The shuttle vector is then recovered and transferred to a mammalian cell for expression.
    Type: Grant
    Filed: December 9, 1998
    Date of Patent: May 21, 2002
    Assignee: Rigel Pharmaceuticlas, Inc.
    Inventors: Ying Luo, Pei Wen Yu, James Lorens
  • Patent number: 6280937
    Abstract: The invention provides shuttle vectors, and methods of using shuttle vectors, capable of expression in, at least, a mammalian cell. Furthermore, the shuttle vectors are capable of replication in at least yeast, and optionally, bacterial cells. Also provided is a method wherein yeast are transformed with a shuttle vector as provided herein. Heterologous nucleic acids flanked by 5′ and 3′ ends identical to a homologous recombination site within the shuttle vector are introduced to the transformed yeast and allowed to homologously recombine with the shuttle vector such that they are inserted into the vector by the yeast organism. The shuttle vector is then recovered and transferred to a mammalian cell for expression.
    Type: Grant
    Filed: August 14, 1998
    Date of Patent: August 28, 2001
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Ying Luo, Pei Wen Yu, James Lorens
  • Patent number: 4095363
    Abstract: A spur-less hammer type breech block action for a breech loading single shot firearm which has a breech block within a vertical mortise in the receiver which is lowered by a finger lever pivoting on a pin.
    Type: Grant
    Filed: July 26, 1976
    Date of Patent: June 20, 1978
    Inventor: James Loren Riedl